Clinical trial
Comparison Between Symbicort® and Prednisolone in COPD
NCT00259779 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00259779 |
|---|---|
| Title | Comparison Between Symbicort® and Prednisolone in COPD |
| Official title | A Randomised, Double Blind, Double Dummy, Multicentre Phase III Study Comparing the Efficacy of Budesonide/Formoterol (Symbicort® Forte Turbuhaler®) and Oral Prednisolone + Formoterol (Oxis® Turbuhaler) During Two Weeks, in COPD Patients With an Acute Exacerbation, Followed by Twelve Weeks Open… |
| Acronym | SPACE |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | budesonide/formoterol, Prednisolone |
| Enrollment | 120 |
| Start date | Sep 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Dec 1, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Denmark, Finland, Germany, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: